Literature DB >> 17199456

Elderly women diagnosed with nonspecific chest pain may be at increased cardiovascular risk.

Jennifer G Robinson1, Robert Wallace, Marian Limacher, Alicia Sato, Barbara Cochrane, Sylvia Wassertheil-Smoller, Judith K Ockene, Patricia L Blanchette, Marcia G Ko.   

Abstract

BACKGROUND: Women are more likely than men to have nonspecific chest pain (NSCP) symptoms. The long-term outcomes in women discharged with a diagnosis of NSCP are unknown.
METHODS: The Women's Health Initiative Observational Study enrolled postmenopausal women aged 50-79 years. After excluding those with prior cardiovascular disease (CVD), 83,622 women were studied. NSCP cases were defined as having an initial primary hospital discharge diagnosis of NSCP (ICD-9 codes 786.50, 786.51, 786.59) without a prior diagnosis of coronary heart disease (CHD). Risks of subsequent CHD events were estimated from Cox proportional hazard ratio (HR) models stratified by clinic and adjusted for baseline age, cardiovascular risk factors, and hormone use.
RESULTS: Over an average of 8 years of follow-up, 11% (230 of 2,092) of women with NSCP experienced a cardiovascular event compared with 9.5% (7,724 of 81,530) who did not. Compared with women without a hospitalization for NSCP during follow-up, those with NSCP had a greater than 2-fold higher risk of a subsequent hospitalization for clinically diagnosed angina (HR 2.18, 95% CI 1.66-2.86) and at least a 1.5-fold higher risk of nonfatal myocardial infarction (MI) (HR 1.59, 1.10-2.31), revascularization (HR 1.67, 1.28-2.20), and congestive heart failure (HR 1.75, 1.27-2.41). Women with NSCP who subsequently experienced a CHD event were more likely to be over age 65 or to have cardiovascular risk factors.
CONCLUSIONS: Older women discharged with a diagnosis of NSCP may be at increased risk of CHD morbidity. Further research is needed to replicate these findings in other populations.

Entities:  

Mesh:

Year:  2006        PMID: 17199456     DOI: 10.1089/jwh.2006.15.1151

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  3 in total

1.  Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan.

Authors:  Chih-Chao Yang; Hon-Kan Yip; Kuan-Hung Chen; Cheuk-Kwan Sun; Yen-Ta Chen; Han-Tan Chai; Pei-Hsun Sung; Hsin-Ju Chiang; Sheung-Fat Ko; Sheng-Ying Chung; Chih-Hung Chen; Kun-Chen Lin; Pao-Yuan Lin; Jiunn-Jye Sheu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.

Authors:  Martha Gulati; Rhonda M Cooper-DeHoff; Candace McClure; B Delia Johnson; Leslee J Shaw; Eileen M Handberg; Issam Zineh; Sheryl F Kelsey; Morton F Arnsdorf; Henry R Black; Carl J Pepine; C Noel Bairey Merz
Journal:  Arch Intern Med       Date:  2009-05-11

3.  Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women's Ischemic Syndrome Evaluation study (WISE).

Authors:  Erika Jones; B Delia Johnson; Leslee J Shaw; May Bakir; Janet Wei; Puja K Mehta; Margo Minissian; Carl J Pepine; Steven E Reis; Sheryl F Kelsey; Eileen Handberg; Vera Bittner; George Sopko; C Noel Bairey Merz
Journal:  Int J Cardiol Heart Vasc       Date:  2020-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.